Form 4 Tracker
Enliven Therapeutics, Inc.
ELVN

27 insider filings · Latest: Jun 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 7, 2025Aug 7 8:19 PMPatel Anish
Proposed Sale
6,667$18.84$125.6K

View →

Jul 28, 2025Jul 28 8:09 PMHohl Benjamin
Proposed Sale
4,250$21.20$90.1K

View →

Jul 21, 2025Jul 21 8:10 PMLyssikatos Joseph P
Proposed Sale
12,500$22.66$283.3K

View →

Jul 17, 2025Jul 17 8:13 PMKintz Samuel
Proposed Sale
12,500$21.46$268.3K

View →

Jul 7, 2025Jul 7 8:15 PMPatel Anish
Proposed Sale
6,667$20.73$138.2K

View →

Jun 27, 2025Jun 27 8:01 PMHohl Benjamin
Proposed Sale
4,250$21.52$91.5K

View →

Jun 20, 2025Jun 20 8:02 PMLyssikatos Joseph P
Proposed Sale
12,500$21.57$269.6K

View →

Jun 17, 2025Jun 17 8:15 PMKintz Samuel
Proposed Sale
12,500$23.09$288.6K

View →

Jun 13, 2025Jun 13 8:08 PMHohl Benjamin
Proposed Sale
3,000$19.99$60.0K

View →

Jun 9, 2025Jun 9 8:21 PMPatel Anish
Proposed Sale
6,667$20.74$138.3K

View →

Jun 3, 2025Jun 3 9:34 PMKintz Samuel
Proposed Sale
7,500$19.14$143.6K

View →

Jun 3, 2025Jun 3 9:14 PMLyssikatos Joseph P
Proposed Sale
7,500$19.14$143.6K

View →

May 27, 2025May 27 8:03 PMHohl Benjamin
Proposed Sale
3,250$16.40$53.3K

View →

May 19, 2025May 19 8:22 PMKintz Samuel
Proposed Sale
5,000$16.86$84.3K

View →

May 19, 2025May 19 8:21 PMLyssikatos Joseph P
Proposed Sale
5,000$16.86$84.3K

View →

May 7, 2025May 7 8:11 PMPatel Anish
Proposed Sale
6,667$19.69$131.3K

View →

May 1, 2025May 1 8:03 PMLyssikatos Joseph P
Proposed Sale
7,500$18.94$142.1K

View →

May 1, 2025May 1 8:02 PMKintz Samuel
Proposed Sale
7,500$18.94$142.1K

View →

Apr 21, 2025Apr 21 8:28 PMLyssikatos Joseph P
Proposed Sale
5,000$16.53$82.7K

View →

Apr 17, 2025Apr 17 8:19 PMKintz Samuel
Proposed Sale
5,000$16.07$80.3K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 17, 2026Jun 22 9:13 PMBenjamin HohlCHIEF FINANCIAL OFFICER
Option Exercise
6,018$2.4886,038(D)

View →

Jun 17, 2026Jun 22 9:11 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48121,268(D)

View →

May 18, 2026May 20 8:18 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48126,268(D)

View →

Apr 17, 2026Apr 22 12:40 AMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48131,268(D)

View →

Mar 25, 2026Mar 27 8:57 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
40,000$2.48136,268(D)

View →

Mar 17, 2026Mar 19 9:50 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48176,268(D)

View →

Mar 10, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
10,129$2.48181,268(D)

View →

Mar 9, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
29,871$2.48191,397(D)

View →

Feb 17, 2026Feb 19 11:36 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
45,000$2.48221,268(D)

View →

Feb 12, 2026Feb 18 1:01 AMLori Anne KunkelDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 1:00 AMRichard A. HeymanDirector
Grant/Award
19,234$27.1619,234(D)

View →

Feb 12, 2026Feb 18 12:59 AMRishi GuptaDirector
Grant/Award
35,569$27.161,580(D)

View →

Feb 12, 2026Feb 18 12:57 AMScott J. GarlandDirector
Grant/Award
1,427$27.161,427(D)

View →

Feb 12, 2026Feb 18 12:56 AMMika K DerynckDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 12:56 AMJake BauerDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 12:55 AMRahul D. BallalDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 12:53 AMAnish PatelCHIEF OPERATING OFFICER
Grant/Award
120,000$27.16120,000(D)

View →

Feb 12, 2026Feb 18 12:52 AMJoseph P LyssikatosCHIEF SCIENTIFIC OFFICER
Grant/Award
112,500$27.16112,500(D)

View →

Feb 12, 2026Feb 18 12:49 AMBenjamin HohlCHIEF FINANCIAL OFFICER
Grant/Award
150,000$27.16150,000(D)

View →

Feb 12, 2026Feb 18 12:47 AMHelen Louise CollinsCHIEF MEDICAL OFFICER
Grant/Award
150,000$27.16150,000(D)

View →